CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 10,000 shares at $61.87 ($618,657)
- 4 Grant or award President & COO acquired 14,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 11,000 shares (grant or award)
- 4 Option exercise Director acquired 20,000 shares (option exercise)
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- 4 Shares withheld for taxes President & COO gave up 3,593 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 9,803 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,187 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 1,073 shares (to pay taxes)
- 4 Open-market sale Chief Executive Officer sold 10,000 shares at $78.32 ($783,173)
- 4 Open-market sale Chief Financial Officer sold 1,696 shares at $75.64 ($128,283)
- 10-Q Report Quarterly Report
- 4/A Insider Changes in Ownership
Page 19 of 115 · 2,300 filings